IM Cannabis Corp. (IMCC)
2.35
0.17 (7.80%)
At close: Jan 15, 2025, 10:17 AM
Company Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada.
It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands.
The company serves medical patients and adult-use recreational consumers.
IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
IM Cannabis Corp.
| Country | IL |
| IPO Date | May 20, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 95 |
| CEO | Oren Shuster |
Contact Details
Address: Kibbutz Glil Yam Tel Aviv, IL | |
| Website | https://www.imcannabis.com |
Stock Details
| Ticker Symbol | IMCC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001792030 |
| CUSIP Number | 44969Q208 |
| ISIN Number | CA44969Q3070 |
| Employer ID | 00-0000000 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Oren Shuster | Chief Executive Officer & Director |
| Richard Balla | Chief Executive Officer of Adjupharm |
| Uri Birenberg | Chief Financial Officer |
| Advocate Michal Lebovitz Nissimov | General Counsel |
| Anna Taranko | Director Investor & Public Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 06, 2025 | 6-K | Filing |
| Dec 04, 2024 | 6-K | Filing |
| Nov 20, 2024 | D | Filing |
| Nov 14, 2024 | 6-K | Filing |
| Nov 06, 2024 | 6-K | Filing |
| Nov 05, 2024 | 6-K | Filing |
| Oct 04, 2024 | 6-K | Filing |
| Oct 02, 2024 | 6-K | Filing |
| Oct 02, 2024 | 6-K | Filing |
| Sep 19, 2024 | 20-F/A | [Amend] Filing |